Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03157323 · ClinicalTrials.gov registry record · NA
Low GI Diet in Children and Adolescents With ALL
A NA study of Acute Lymphoblastic Leukemia, Pediatric and Obesity, Pediatric, sponsored by Columbia University.
- Active
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 5
- Study locations
NCT03157323: Active NA study of Acute Lymphoblastic Leukemia, Pediatric and Obesity, Pediatric, sponsored by Columbia University.
NCT03157323 is a NA study of Acute Lymphoblastic Leukemia, Pediatric and Obesity, Pediatric that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 88 participants, below the 113-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (22% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03157323, a NA study of Acute Lymphoblastic Leukemia, Pediatric and Obesity, Pediatric, is active but no longer recruiting, sponsored by Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 5
- Study locations
Study Summary
The study aims to determine the feasibility of a 6-month low glycemic dietary intervention in children and adolescents undergoing treatment for acute lymphoblastic leukemia.
Primary Outcome
Feasibility will be measured by compliance to a low glycemic index diet, which will be measured via 24 dietary recall, using the Automated Self-Administered 24-Hour Dietary Assessment Tool. A dietary recall will be taken at 7 timepoints from diagnosis to end of treatment; each recall will be defined categorically as high compliance (GI score \<55), moderate compliance (GI score 56-69) and low compliance (GI score \>70). Change in glycemic index score will show compliance.
Conditions Studied
Interventions
- BEHAVIORAL Low Glycemic Index Diet
Study Locations (5)
New York
- Roswell Park Cancer Institute - Buffalo
- Columbia University - New York
Connecticut
- Connecticut Children's Medical Center - Hartford
District of Columbia
- Children's National Hospital - Washington D.C.
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT03157323 still lists
NCT03157323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 113-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (22% lower).
The record links to 2 conditions, with Acute Lymphoblastic Leukemia, Pediatric appearing as the primary indexed condition, and to 1 intervention - of which Low Glycemic Index Diet is the first listed.
NCT03157323 lists 5 locations in 4 states (New York, Connecticut, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT03157323 about?
NCT03157323 is a clinical study titled "Low GI Diet in Children and Adolescents With ALL". The study aims to determine the feasibility of a 6-month low glycemic dietary intervention in children and adolescents undergoing treatment for acute lymphoblastic leukemia.
What is the current status of trial NCT03157323?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2017-06-01. Estimated completion is 2026-06.
What conditions does trial NCT03157323 study?
This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia, Pediatric, Obesity, Pediatric.
What interventions are being tested in trial NCT03157323?
The interventions under investigation include: Low Glycemic Index Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03157323?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03157323 being conducted?
This trial has 5 study locations across Connecticut, District of Columbia, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Lymphoblastic Leukemia, Pediatric
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03157323's enrollment target sits among peer trials
88 3rd of 8 higher than 6 of 8 other Acute Lymphoblastic Leukemia, Pediatric trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Lymphoblastic Leukemia, Pediatric trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
RECRUITING · NA
-
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
RECRUITING · Phase 1
-
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI